Lifyorli
NDC 76346-425, Relacorilant, kit, from Corcept Therapeutics Incorporated.
- Product NDC
- 76346-425
- Status
- Listed
- Labeler
- Corcept Therapeutics Incorporated
- Dosage form
- KIT
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220641
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76346-425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76346-425-01 | 76346042501 | 1 BLISTER PACK in 1 CARTON (76346-425-01) / 1 KIT in 1 BLISTER PACK (76346-425-11) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6fcebfb5-19d6-4f63-b852-999d68a13729
Use it
Look up 76346-425 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76346-425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76346-425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.